The prevalence of food allergy has increased in recent decades and is now recognized as a substantial public health burden in developed countries, following the epidemics of asthma and allergic rhinitis that rose to prominence in the last few decades of the 20th century
The typical symptoms of food allergy include disturbances to the skin, respiratory tract and gastrointestinal tract as well as cardiovascular aberrations
A key mechanism to prevent chronic inflammatory diseases, such as food allergies, later in life. Tolerance is acquired, relies on antigen exposure, is antigen-specific and represents a lifelong process that starts prenatally
Innate and adaptive immune responses cooperate in a coordinated fashion to mount tolerance; with regard to food antigens, tolerance requires food antigen exposure, which starts in utero
Extrinsic environmental and lifestyle factors, including the qualitative and quantitative composition of the microbiota, have been linked to food allergies
Major advances have been achieved in basic, translational and clinical research, improving our mechanistic understanding of food allergy and enabling the development of therapeutic and preventive measures
Exciting therapies are in clinical development, including treatment with biological therapies as well as allergen-specific therapies — such as oral, sublingual and epicutaneous immunotherapy
Prevention of food allergies remains a key challenge. To develop effective preventive measures, the contributing factors for the development of food allergies need to be defined
This Primer provides a comprehensive overview of the recent advances in the field of food allergy in terms of mechanistic understanding, diagnostics, prevention and management
Globally, Australia has the highest prevalence of IgE-mediated food allergy, with 10% of infants demonstrating challenge-confirmed allergies to one or more foods
Estimating the prevalence of food allergies is difficult because the gold standard is the performance of a controlled food challenge, which can only be performed in specialized centres
Population-based studies that assess changes in prevalence of food allergy have primarily focused on peanut allergy, with evidence of increasing prevalence in the United Kingdom and United States
Absorption of the allergen through the intestinal epithelium and access to the mucosa and bloodstream where immune effector cells reside are enhanced in those with food allergy. The ingested food allergens interact with IgE and its high-affinity Fc receptor (FcεRI) on mast cells in mucosal tissues and on circulating basophils, leading to the activation of these cells
Food reactions have been associated with elevated plasma levels of PAF, a product of activated macrophages, along with reduced amounts of its inactivating enzyme, PAF acetylhydrolase
The absence of detectable tryptase cannot be taken to exclude the possibility of anaphylaxis in a patient who has experienced an acute reaction to food
In the Mediterranean basin, fruits and vegetables that contain low-molecular-mass lipid transfer proteins (which are highly cross-reactive between foods) are the major cause of anaphylaxis
IgE antibodies that are produced in response to the oligosaccharide galactose-α-1,3-galactose (α-gal), which are typically introduced during tick bites, can lead to reactions that are delayed by several hours when ingesting mammalian meat
Certain murine models administered high-dose intravenous antigen challenge can initiate an anaphylaxis response in the absence of IgE by cognate interaction with specific immunoglobulin G (IgG) antibodies bound to activating Fcγ receptors on effector cells
IgG signals can activate both the classic mast cell pathway of mediator release (similar to the IgE–FcεRI-mediated reactions) and an alternative pathway that results in the production of PAF by macrophages